Skip to main content

Table 2 Overview of instruments per time of assessment

From: Efficacy of a hybrid online training for panic symptoms and agoraphobia: study protocol for a randomized controlled trial

Assessments

Screening

T0

T1

T2

T3

Sociodemographic data

x

-

-

-

-

Suicidality (Item 9, BDI-II)

x

-

-

-

-

Diagnosis (SCID-I, sections for anxiety disorders and current depressive episode)

-

x

-

-

 

Panic and agoraphobia severity, self-rating (PAS)

x

x

x

x

x

Panic and agoraphobia severity, observer-rating (HAM-A)

-

x

x

-

-

Agoraphobic cognitions (ACQ)

-

x

x

x

x

Body sensations (BSQ)

-

x

x

x

x

Agoraphobic avoidance (MI)

-

x

x

x

x

Depressive symptoms (CES-D)

-

x

x

x

x

Quality of life (EQ-5D, SF-12)

-

x

x

x

x

Economic evaluations (TiC-P)

-

x

-

-

x

Negative effects of online health trainings

-

-

(x)

(x)

(x)

Attitudes towards seeking psychological help

-

-

(x)

-

-

User satisfactory

-

-

(x)

-

-

Technology acceptance of smartphone app

-

-

(x)

-

-

Usability of smartphone app (SUS)

-

-

(x)

-

-

  1. T0 = Baseline, T1 = 8 weeks, T2 = 3 months, T4 = 6 months.
  2. Assessments: x = intervention and control group, (x) = intervention group only.
  3. ACQ, Agoraphobic cognitions questionnaire; BDI-II, Beck Depression Inventory II; BSQ, Body sensations questionnaire; CES-D, Center for epidemiological studies depression scale; EQ-5D, EuroQol; HAM-A, Hamilton anxiety scale; MI, Mobility inventory; PAS, Panic and agoraphobia scale; SCID-I, Structured clinical interview for DSM-IV Axis I Disorders; SF-12, Short form 12; SUS, System Usability Scale; TiC-P, Trimbos and the Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry.